Active 0 6 0 6 B-cancer
second 7 13 7 13 I-cancer
malignancy 14 24 14 24 I-cancer
, 24 25 24 25 O
with 26 30 26 30 O
the 31 34 31 34 O
exception 35 44 35 44 O
of 45 47 45 47 O
curatively 48 58 48 58 O
treated 59 66 59 66 O
non 67 70 67 70 B-cancer
- 70 71 70 71 I-cancer
melanoma 71 79 71 79 I-cancer
skin 80 84 80 84 I-cancer
cancer 85 91 85 91 I-cancer
, 91 92 91 92 O
carcinoma 93 102 93 102 B-cancer
in 103 105 103 105 I-cancer
situ 106 110 106 110 I-cancer
, 110 111 110 111 O
or 112 114 112 114 O
superficial 115 126 115 126 B-cancer
bladder 127 134 127 134 I-cancer
cancer 135 141 135 141 I-cancer

Be 0 2 142 144 O
18 3 5 145 147 B-lower_bound
years 6 11 148 153 I-lower_bound
old 12 15 154 157 O
at 16 18 158 160 O
the 19 22 161 164 O
time 23 27 165 169 O
the 28 31 170 173 O
informed 32 40 174 182 O
consent 41 48 183 190 O
form 49 53 191 195 O
is 54 56 196 198 O
signed 57 63 199 205 O

Have 0 4 206 210 O
a 5 6 211 212 O
deleterious 7 18 213 224 O
mutation 19 27 225 233 O
in 28 30 234 236 O
BRCA1/2 31 38 237 244 B-cancer
or 39 41 245 247 O
ATM 42 45 248 251 O

Have 0 4 252 256 O
a 5 6 257 258 O
histologically 7 21 259 273 O
or 22 24 274 276 O
cytologically 25 38 277 290 O
confirmed 39 48 291 300 O
adenocarcinoma 49 63 301 315 B-cancer
or 64 66 316 318 O
poorly 67 73 319 325 O
differentiated 74 88 326 340 O
carcinoma 89 98 341 350 B-cancer
of 99 101 351 353 I-cancer
the 102 105 354 357 I-cancer
prostate 106 114 358 366 I-cancer

Pre 0 3 367 370 O
- 3 4 370 371 O
existing 4 12 371 379 O
duodenal 13 21 380 388 O
stent 22 27 389 394 O
and/or 28 34 395 401 O
any 35 38 402 405 O
gastrointestinal 39 55 406 422 B-chronic_disease
disorder 56 64 423 431 I-chronic_disease
or 65 67 432 434 O
defect 68 74 435 441 O
that 75 79 442 446 O
would 80 85 447 452 O
, 85 86 452 453 O
in 87 89 454 456 O
the 90 93 457 460 O
opinion 94 101 461 468 O
of 102 104 469 471 O
the 105 108 472 475 O
investigator 109 121 476 488 O
, 121 122 488 489 O
interfere 123 132 490 499 O
with 133 137 500 504 O
absorption 138 148 505 515 O
of 149 151 516 518 O
rucaparib 152 161 519 528 B-treatment

Prior 0 5 529 534 B-treatment
treatment 6 15 535 544 I-treatment
with 16 20 545 549 O
any 21 24 550 553 O
PARP 25 29 554 558 B-treatment
inhibitor 30 39 559 568 I-treatment
, 39 40 568 569 O
mitoxantrone 41 53 570 582 B-treatment
, 53 54 582 583 O
cyclophosphamide 55 71 584 600 B-treatment
or 72 74 601 603 O
any 75 78 604 607 O
platinum 79 87 608 616 B-treatment
- 87 88 616 617 I-treatment
based 88 93 617 622 I-treatment
chemotherapy 94 106 623 635 I-treatment

Symptomatic 0 11 636 647 B-cancer
and/or 12 18 648 654 I-cancer
untreated 19 28 655 664 I-cancer
central 29 36 665 672 I-cancer
nervous 37 44 673 680 I-cancer
system 45 51 681 687 I-cancer
metastases 52 62 688 698 I-cancer

molecular 0 9 699 708 O
evidence 10 18 709 717 O
of 19 21 718 720 O
other 22 27 721 726 O
homologous 28 38 727 737 B-chronic_disease
recombination 39 52 738 751 I-chronic_disease
deficiency 53 63 752 762 I-chronic_disease

prior 0 5 763 768 O
taxane 6 12 769 775 B-treatment
- 12 13 775 776 I-treatment
based 13 18 776 781 I-treatment
chemotherapy 19 31 782 794 I-treatment
, 31 32 794 795 O
for 33 36 796 799 O
castration 37 47 800 810 B-chronic_disease
- 47 48 810 811 I-chronic_disease
resistant 48 57 811 820 I-chronic_disease
disease 58 65 821 828 I-chronic_disease

